nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo searchdiv qikanlogo popupnotification paper paperNew
2025, 04, v.39 60-65
基于AHP-EWM结合Box-Behnken响应面法优化桂龙巴布贴的提取工艺
基金项目(Foundation): 广东省科技计划项目(2017A070701017)
邮箱(Email): tiening1111@163.com;
DOI: 10.13728/j.1673-6427.2025.04.010
摘要:

目的 优化桂龙巴布贴提取工艺参数。方法 以HPLC法测定方中桂皮醛(Cin)、香蒲新苷(Typ)、异鼠李素-3-O-新橙皮苷(Iso)含量及干膏率为评价指标,采用层次分析-熵权法(AHP-EWM)对权重系数进行计算,结合响应面法(Box-Behnken)优选桂龙巴布贴提取工艺。结果 确定Cin、Typ、Iso含量、干膏率的权重系数分别为0.844 5、0.091 5、0.056 4、0.007 6。经综合评分后,建立了预测数学模型。确定最佳工艺为优选的工艺为:加水回流提取2次,每次加10倍量水,提取70 min,滤过。在此条件下的综合评分为98.702,与模型预测值99.361差值较小,RSD小于3%,工艺稳定。结论 拟定的桂龙巴布贴提取工艺稳定可行,为临床更好地开发利用桂龙巴布贴提供了科学依据和技术支持。

Abstract:

Objective To optimize the extraction process parameters of Guilong cataplasm.Methods The HPLC method was used to determine the components of cinnamaldehyde,chamomile neoside,isorhamnetin-3-O-neohesperidin and the dry extract rate of the formula as the evaluation indexes,and the weight coefficients were calculated by using AHP-EWM,and the extraction process of Guilong cataplasm was preferred by combining the Box-Behnken Response Surface Method.Results The weighting coefficients of Cin,Typ,Iso content and dry paste rate were determined as 0.844 5,0.091 5,0.056 4 and 0.007 6,respectively.After the combined scoring,the predictive mathematical model was developed.The optimal preparation was as follows:heated and refluxed for twice,added 10 times the amount of water and 70 min for each time.The composite score under this condition was 98.702,which was a very small difference from the model prediction of 99.361,with an RSD of less than 3%,and the process was stable.Conclusion The proposed extraction process of Guilong cataplasm is stable and feasible,which provides scientific basis and technical support for better clinical development and utilisation of Guilong cataplasm.

参考文献

[1]卢春颜,邱建永,洪笃云.桂龙风湿巴布剂治疗类风湿性关节炎患者的临床效果[J].中国药物经济学,2021,16(8):41-43,47.

[2]李智勇,邱建永,欧阳炜,等.均匀设计法优选桂龙凝胶膏剂的基质处方[J].今日药学,2014,24(10):712-715.

[3]国家药典委员会.中华人民共和国药典:一部[S].北京:中国医药科技出版社,2020:85.

[4]卢雪雪,田慧.肉桂的活性成分及其药理作用研究进展[J].壮瑶药研究,2023(2):16-20,382.

[5]唐丹丹,蒙泔竹,曾英港,等.肉桂油抗炎与抗肿瘤作用及其机制研究进展[J].食品与药品,2023,25(6):591-596.

[6]陈瑾,郝二伟,冯旭,等.蒲黄化学成分、药理作用及质量标志物(Q-marker)的预测分析[J].中草药,2019,50(19):4729-4740.

[7]胡立宏,房士明,刘虹,等.蒲黄的化学成分和药理活性研究进展[J].天津中医药大学学报,2016,35(2):136-140.

[8]李鑫,闫影,孙志伟,等.基于经典名方中药复方颗粒剂的设计研究进展[J].药学研究,2020,39(11):666-669.

[9]白兆娟,王雪梅,黄清杰,等.基于AHP-熵权法的D-最优设计响应面法优化云香喷剂提取工艺[J].中国中医药信息杂志,2021,28(12):82-87.

[10]李磊,程虹毓,朱玉野,等.多指标综合评分法优化栀子柏皮汤[J].中成药,2015,37(2):306-310.

[11]张琳,周欣,闫丹,等.基于CRITIC-AHP权重分析法结合Box-Behnken设计-响应面法优选陈皮饮片炮制工艺[J].中草药,2018,49(16):3829-3834.

[12]张勇,温蕾.中医对风湿性关节炎的病因病机认识及治疗现状研究[J].中医临床研究,2018,10(35):144-146.

[13]雷静,谭婷,周亮,等.通痹止痛散外用蜡疗联合中药内服对类风湿性关节炎活动期患者关节急性疼痛、肿胀程度和实验室指标的影响[J].四川中医,2022,40(7):124-128.

[14]王序.外用清热利湿通络中药治疗湿热痹阻型类风湿性关节炎的效果研究[J].中国现代药物应用,2021,15(1):213-215.

[15]范兴刚.为风湿性关节炎患者联合进行中药与针灸治疗的效果分析[J].当代医药论丛,2015,13(12):37-38.

[16]卢春颜,邱建永.桂龙风湿巴布贴治疗风湿性关节炎的实验研究[J].中国现代药物应用,2016,10(9):285-286.

[17]齐红梅.桂枝茯苓胶囊在子宫内膜异位症患者中的应用及对子宫动脉血流动力学的影响[J].中华养生保健,2024,42(16):35-38.

[18]孔祥鹏,陈佩东,张丽,等.蒲黄及蒲黄炭对血瘀大鼠血液流变性及凝血时间的影响[J].中国实验方剂学杂志,2011,17(6):129-132.

[19]徐敏,杭燕,王钤.蒲黄热奄包对胰岛素注射致皮下脂肪增生患者血糖及皮肤耐受的影响[J].河北中医,2023,45(9):1490-1493.

[20]王维维,刘小红,张人龙.大数据环境下智慧物流发展水平测度研究[J].物流科技,2024,47(19):21-27.

基本信息:

DOI:10.13728/j.1673-6427.2025.04.010

中图分类号:R283.6

引用信息:

[1]邱建永,王思丰,李智勇等.基于AHP-EWM结合Box-Behnken响应面法优化桂龙巴布贴的提取工艺[J].现代中药研究与实践,2025,39(04):60-65.DOI:10.13728/j.1673-6427.2025.04.010.

基金信息:

广东省科技计划项目(2017A070701017)

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文